Civic Intelligence

Clinical Research Foundation Inc.

990 • Fiscal year 2016 • EIN 61-1144514

Jan 01, 2016 to Dec 31, 2016 • Filed on Apr 25, 2017

800 Zorn Avenue Suite 151Louisville, KY 40206

(502) 287-6260

Siviq Scores

Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.

Liabilities / Assets

47th percentile

0.03x

Higher debt load relative to assets than 47% of similar nonprofits.

2016 filings • 501(c)3 • $500k-$1M nonprofits • Source year 2016

Liabilities / Revenue

53rd percentile

0.05x

Higher debt load relative to revenue than 53% of similar nonprofits.

2016 filings • 501(c)3 • $500k-$1M nonprofits • Source year 2016

Net Margin

81st percentile

24%

Higher net margin than 81% of similar nonprofits.

2016 filings • 501(c)3 • $500k-$1M nonprofits • Source year 2016

Top Officer Pay

63rd percentile

$46,169

Higher top officer pay than 63% of similar nonprofits.

Top officer pay equals 8.6% of source-year revenue.

2016 filings • 501(c)3 • $500k-$1M nonprofits • Source year 2016

Asset Growth

77th percentile

18%

Faster asset growth than 77% of similar nonprofits.

2016 filings • 501(c)3 • $500k-$1M nonprofits • Annualized from 2015 to 2016

Revenue Growth

14th percentile

-24%

Faster revenue growth than 14% of similar nonprofits.

2016 filings • 501(c)3 • $500k-$1M nonprofits • Annualized from 2015 to 2016

Assets

Up

$863,667

Up $130,375 (+18%) from 2015

Net Assets

Up

$838,275

Up $126,836 (+18%) from 2015

Liabilities

Up

$25,392

Up $3,539 (+16%) from 2015

Revenue

Down

$537,657

Down $168,322 (-24%) from 2015

Expenses

Down

$410,821

Down $160,477 (-28%) from 2015

Net Income

Down

$126,836

Down $7,845 (-5.8%) from 2015

Historical Trend

Balance Sheet Trend

The highlighted filing sits inside the broader history for assets, liabilities, and net assets.

$1.0M$500K$0Assets 2010: $381,617Liabilities 2010: $0Net Assets 2010: $381,6172010Assets 2011: $495,033Liabilities 2011: $0Net Assets 2011: $495,0332011Assets 2012: $702,584Liabilities 2012: $0Net Assets 2012: $702,5842012Assets 2013: $674,250Liabilities 2013: $0Net Assets 2013: $674,2502013Assets 2014: $578,883Liabilities 2014: $2,125Net Assets 2014: $576,7582014Assets 2015: $733,292Liabilities 2015: $21,853Net Assets 2015: $711,4392015Assets 2016: $863,667Liabilities 2016: $25,392Net Assets 2016: $838,2752016Assets 2017: $672,546Liabilities 2017: $48,481Net Assets 2017: $624,0652017Assets 2018: $482,383Liabilities 2018: $39,322Net Assets 2018: $443,0612018Assets 2019: $326,853Liabilities 2019: $12,293Net Assets 2019: $314,5602019Assets 2020: $244,533Liabilities 2020: $5,615Net Assets 2020: $238,9182020Assets 2021: $267,190Liabilities 2021: $0Net Assets 2021: $267,1902021Assets 2022: $232,461Liabilities 2022: $0Net Assets 2022: $232,4612022Assets 2023: $256,437Liabilities 2023: $2,730Net Assets 2023: $253,7072023Assets 2024: $395,422Liabilities 2024: $65,069Net Assets 2024: $330,3532024

Highlighted filing

2016

Assets$863,667
Liabilities$25,392
Net Assets$838,275

Operations Trend

Revenue, expenses, and net income across loaded years, with this filing highlighted.

$1.0M$500K$0-$500KExpenses 2010: $343,0872010Expenses 2011: $365,6792011Expenses 2012: $388,6532012Revenue 2013: $641,413Expenses 2013: $669,747Net Income 2013: -$28,3342013Revenue 2014: $485,080Expenses 2014: $584,336Net Income 2014: -$99,2562014Revenue 2015: $705,979Expenses 2015: $571,298Net Income 2015: $134,6812015Revenue 2016: $537,657Expenses 2016: $410,821Net Income 2016: $126,8362016Revenue 2017: $195,155Expenses 2017: $409,365Net Income 2017: -$214,2102017Revenue 2018: $264,093Expenses 2018: $445,097Net Income 2018: -$181,0042018Revenue 2019: $259,788Expenses 2019: $388,388Net Income 2019: -$128,6002019Revenue 2020: $449,134Expenses 2020: $523,458Net Income 2020: -$74,3242020Revenue 2021: $628,030Expenses 2021: $599,758Net Income 2021: $28,2722021Revenue 2022: $388,144Expenses 2022: $394,996Net Income 2022: -$6,8522022Revenue 2023: $330,716Expenses 2023: $309,470Net Income 2023: $21,2462023Revenue 2024: $375,042Expenses 2024: $287,830Net Income 2024: $87,2122024

Highlighted filing

2016

Revenue$537,657
Expenses$410,821
Net Income$126,836
Jump To
Filing Snapshot
Filing Period
Jan 1, 2016 to Dec 31, 2016
Signed
Apr 25, 2017
Return Version
2016v3.0
Gross Receipts
$537,657
Mission and Program Overview

Mission

Clinical Research Foundation, Inc. (CRF) promotes quality scientific research to improve the medical treatment, general health, and quality of life for our nation's veterans by providing a flexible funding mechanism to Robley Rex VA Medical Center researchers for non-VA funded studies or trials

Clinical research foundation, inc. (crf) promotes quality research to improve the medical treatment, general health and quality of life for our nations veterans by promoting a flexible funding mechanism to robley rex va medical center researchers for non-va funded studies or trials.

Balance Sheet Detail
LineBeginningEndChange
Assets
Savings and Temporary Cash Investments$152,000$449,000▲ $297,000
Cash and Non-Interest-Bearing Accounts$526,077$402,691▼ $123,386
Pledges and Grants Receivable$53,137--
Accounts Receivable-$8,780-
Prepaid Expenses and Deferred Charges$2,078$3,196▲ $1,118
Total Assets$733,292$863,667▲ $130,375
Liabilities
Accounts Payable and Accrued Expenses$21,853$25,392▲ $3,539
Total Liabilities$21,853$25,392▲ $3,539
Net Assets / Fund Balance
Unrestricted Net Assets$711,439$838,275▲ $126,836
Total Net Assets Fund Balance$711,439$838,275▲ $126,836
Total Liabilities and Net Assets / Fund Balance$733,292$863,667▲ $130,375
Compensation and Service Providers

Employees

NameTitleFull / Part TimeBaseTotal
Kimberly KelleyExecutive DiPT$46,169$46,169

Board Members and Trustees

Revenue and Support

Revenue Composition

Contributions and Grants
$0
Program Service Revenue
$535,287
Investment Income
$2,370
Other Revenue
$0
Change in Net Assets
$126,836

Audited Revenue Reconciliation

Revenue per Audited Statements
$537,657
Total Revenue per Audited Statements
$537,657
Total Revenue per Form 990
$537,657
Expenses and Functional Allocation

Major Expense Lines

Line ItemAmount
Salaries, Compensation, and Employee Benefits$235,411
Other Expenses$175,410
Grants and Similar Amounts Paid$0
Professional Fundraising Fees$0
Total Fundraising Expense$0

Functional Expense Allocation

Line ItemProgramManagementFundraisingTotal
Other Salaries and Wages$161,518$9,670-$171,188
Current Officers, Directors, Trustees, and Key Employees-$46,169-$46,169
Fees for Services Other$26,200--$26,200
Payroll Taxes$13,548$4,506-$18,054
Conferences and Meetings$3,822$2,553-$6,375
Fees for Services Accounting-$5,000-$5,000
Insurance-$2,109-$2,109
Travel$635$1,050-$1,685
Other Expenses$1,419$2,520-$1,419
Information Technology$995$239-$1,234
Advertising$540$674-$1,214
Office Expenses$42$700-$742
All Other Expenses-$165-$165
Total Functional Expenses$331,716$79,105$0$410,821

Audited Expense Reconciliation

Line ItemAmount
Expenses per Audited Statements$410,821
Total Expenses per Audited Statements$410,821
Total Expenses per Form 990$410,821
Fundraising, Events, and Gaming
Fundraising activities
No
Gaming activities
No
Professional fundraiser used
No

Fundraising and Gaming Totals

Line ItemAmount
Professional Fundraising Fees$0
Political and Lobbying Activity
Political campaign activity
No
Lobbying activity
No
Subject to proxy tax
No
Governance and Compliance

Governance Checklist

Compiled or reviewed by an accountant
No
Annual disclosure for covered persons
Yes
Audit committee
Yes
Backup withholding compliance
Yes
Business relationship with family members
No
Business relationship with organization members
No
Material changes to governing documents
No
Compensation from other sources disclosed
No
CEO compensation reviewed
Yes
Other officer compensation reviewed
No
Conflict-of-interest policy
Yes
Audited financial statements prepared
No
Key decisions subject to board approval
No
Management duties delegated
No

Governance Explanations

Form 990, Page 6, Part VI, Line 11B

The form 990 is reviewed and approved by the entire board at a scheduled meeting.

Form 990, Page 6, Part VI, Line 12C

On an annual basis the board of directors/officers/employees must answer and sign a specific questionnaire designed to highlight any potential confilict of interest. The questionnaire is reviewed and housed by crf administration.

Form 990, Page 6, Part VI, Line 15A

Compensation determination for the executive director must be reviewed and approved by the board of directors.

Form 990, Page 6, Part VI, Line 19

UPON REQUEST.

Filing and Contact Details

Filer

Filer Name
Clinical Research Foundation Inc
EIN
61-1144514
Phone
5022876260
Address
800 ZORN AVENUE SUITE 151, LOUISVILLE, KY 40206

Signing Officer

Name
Kimberly Kelley
Title
Executive Director
Phone
5022876260
Signed
2017-04-25

Organization Details

Principal Officer
Kimberly Kelley
Formed
1988
Legal Domicile
Ky
Voting Board Members
7
Independent Board Members
7
Employees
14
Volunteers
7

Preparer

Firm
Baldwin Cpas Pllc
Address
943 S 1ST STREET, LOUISVILLE, KY 40203
Preparer
Barbara Lasky
Phone
5025849793
Supplemental Narrative

Additional Explanations

FORM 990 - ORGANIZATION'S MISSION

Clinical research foundation, inc. Facilitates research at the robley rex va medical center (rrvamc) in louisville, ky by providing a mechanism for rrvamc researchers to participate in research programs including clinical trials that are funded by private or non-va public sources.

Form 990, Page 2, Part III, Line 4C

Hours after the completion of blood and fluid.

Form 990, Page 2, Part III, Line 4D

Marsano, m.d. (galectin) - treatment of liver fibrosis and portal hypertention in patients with cirrhosis. Expense - 1,715. Revenue - 8,125 mokshagundam, m.d. (boehringer ingelheim)(novo nordisk) - diabetic clinical trials. Expense - 3,515. Revenue - 11,153. Matheson, phd (kentucky organ donor affiliates) - induced cell dysfuction in brain death. Expense - 5,298 revenue - 0 nakamatsu, m.d. (cempra) - community-aquired bacterial pneumonia drug therapy expense - 1,215 revenue - 0 peyrani, m.d. (pfizer) - hospitalized adults with pneumococcal infection study. Expense - 0 revenue - 4,500 research initiative - hired research coordinator and mental health facilitator to develop new research projects. Expense - 30,069 revenue - 0 stoddard, m.d. (brigham woman's hospital)(pfizer)(boehringer ingelheim) (novartis) - cardiovascular studies expense - 32,090 revenue - 83,114 other project support - vmu, hendler, m.d. Pharm, projects with rev/exp< 2,000. Expense - 10,355 revenue - 0

Financial Statement Notes

Schedule D, Page 3, Part X

Management has concluded that any tax positions that would not meet the more likely-than-not criterion of fasb asc 740-10 would be immaterial to the financial statements taken as a whole. Accordingly, the accompanying financial statements do not include any provision for uncertain tax positions, and no related interest or penalties have been recorded in the statement of revenue, expenses and other changes in net assets or accrued in the statement of assets and net assets.

Raw XML Appendix357 raw XML fields

This appendix keeps the raw XML leaves available for debugging and edge-case review. The human report above is the primary experience.

Path#Value
IRS990/AccountantCompileOrReviewInd0false
IRS990/AccountsPayableAccrExpnssGrp/BOYAmt021853
IRS990/AccountsPayableAccrExpnssGrp/EOYAmt025392
IRS990/AccountsReceivableGrp/EOYAmt08780
IRS990/ActivitiesConductedPrtshpInd0false
IRS990/ActivityOrMissionDesc0CLINICAL RESEARCH FOUNDATION, INC. (CRF) PROMOTES QUALITY RESEARCH TO IMPROVE THE MEDICAL TREATMENT, GENERAL HEALTH AND QUALITY OF LIFE FOR OUR NATIONS VETERANS BY PROMOTING A FLEXIBLE FUNDING MECHANISM TO ROBLEY REX VA MEDICAL CENTER RESEARCHERS FOR NON-VA FUNDED STUDIES OR TRIALS.
IRS990/AdvertisingGrp/ManagementAndGeneralAmt0674
IRS990/AdvertisingGrp/ProgramServicesAmt0540
IRS990/AdvertisingGrp/TotalAmt01214
IRS990/AllOtherExpensesGrp/ManagementAndGeneralAmt0165
IRS990/AllOtherExpensesGrp/TotalAmt0165
IRS990/AnnualDisclosureCoveredPrsnInd0true
IRS990/AuditCommitteeInd0true
IRS990/BackupWthldComplianceInd0true
IRS990/BooksInCareOfDetail/PersonNm0THE ORGANIZATION
IRS990/BooksInCareOfDetail/PhoneNum05022876260
IRS990/BooksInCareOfDetail/USAddress/AddressLine1Txt0800 ZORN AVENUE STE 151
IRS990/BooksInCareOfDetail/USAddress/CityNm0LOUISVILLE
IRS990/BooksInCareOfDetail/USAddress/StateAbbreviationCd0KY
IRS990/BooksInCareOfDetail/USAddress/ZIPCd040206
IRS990/BusinessRlnWithFamMemInd0false
IRS990/BusinessRlnWithOfficerEntInd0false
IRS990/BusinessRlnWithOrgMemInd0false
IRS990/CashNonInterestBearingGrp/BOYAmt0526077
IRS990/CashNonInterestBearingGrp/EOYAmt0402691
IRS990/ChangeToOrgDocumentsInd0false
IRS990/CollectionsOfArtInd0false
IRS990/CompCurrentOfcrDirectorsGrp/ManagementAndGeneralAmt046169
IRS990/CompCurrentOfcrDirectorsGrp/TotalAmt046169
IRS990/CompensationFromOtherSrcsInd0false
IRS990/CompensationProcessCEOInd0true
IRS990/CompensationProcessOtherInd0false
IRS990/ConferencesMeetingsGrp/ManagementAndGeneralAmt02553
IRS990/ConferencesMeetingsGrp/ProgramServicesAmt03822
IRS990/ConferencesMeetingsGrp/TotalAmt06375
IRS990/ConflictOfInterestPolicyInd0true
IRS990/ConservationEasementsInd0false
IRS990/ConsolidatedAuditFinclStmtInd0false
IRS990/CreditCounselingInd0false
IRS990/CYBenefitsPaidToMembersAmt00
IRS990/CYContributionsGrantsAmt00
IRS990/CYGrantsAndSimilarPaidAmt00
IRS990/CYInvestmentIncomeAmt02370
IRS990/CYOtherExpensesAmt0175410
IRS990/CYOtherRevenueAmt00
IRS990/CYProgramServiceRevenueAmt0535287
IRS990/CYRevenuesLessExpensesAmt0126836
IRS990/CYSalariesCompEmpBnftPaidAmt0235411
IRS990/CYTotalExpensesAmt0410821
IRS990/CYTotalFundraisingExpenseAmt00
IRS990/CYTotalProfFndrsngExpnsAmt00
IRS990/CYTotalRevenueAmt0537657
IRS990/DecisionsSubjectToApprovaInd0false
IRS990/DeductibleArtContributionInd0false
IRS990/DeductibleNonCashContriInd0false
IRS990/DelegationOfMgmtDutiesInd0false
IRS990/Desc0PI-KRISHNASAMY, SATHYA, M.D. (KRIS4191, KRISDEV, KRISNOVO, KRISTAIN) -- DIABETES AND RELATED CARDIOVASCULAR COMPLICATIONS ARE MAJOR CAUSES OF MORBIDITY AND MORTALITY AMONG VETERANS. THE NOVO STUDIES ARE WELL DESIGNED INTERNATIONAL LONGITUDINAL RANDOMIZED CLINICAL TRIALS MEASURING CV OUTCOMES IN VETERANS WITH TYPE 2 DIABETES. SUCH STUDIES ALLOW OUR DIABETIC PATIENTS, UNDER CLOSELY MONITORED CARE, TO RECEIVE THE LATEST DRUGS AND TREATMENT INFORMATION CONCERNING THEIR DISEASE. IT ALSO SHEDS LIGHT INTO DISEASE SPECIFIC PATTERNS WHICH MAY BE UNIQUE TO OUR VETERAN POPULATION WHICH ENHANCES OUR KNOWLEDGE TO IMPROVE VETERANS' OVERALL HEALTH.
IRS990/DescribedInSection501c3Ind0true
IRS990/DisregardedEntityInd0false
IRS990/DocumentRetentionPolicyInd0true
IRS990/DonorAdvisedFundInd0false
IRS990/ElectionOfBoardMembersInd0false
IRS990/EmployeeCnt014
IRS990/EmploymentTaxReturnsFiledInd0true
IRS990/EngagedInExcessBenefitTransInd0false
IRS990/ExpenseAmt067209
IRS990/FamilyOrBusinessRlnInd0false
IRS990/FederalGrantAuditRequiredInd0false
IRS990/FeesForServicesAccountingGrp/ManagementAndGeneralAmt05000
IRS990/FeesForServicesAccountingGrp/TotalAmt05000
IRS990/FeesForServicesOtherGrp/ProgramServicesAmt026200
IRS990/FeesForServicesOtherGrp/TotalAmt026200
IRS990/ForeignActivitiesInd0false
IRS990/ForeignFinancialAccountInd0false
IRS990/ForeignOfficeInd0false
IRS990/Form8282PropertyDisposedOfInd0false
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt03.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt11.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt21.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt31.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt41.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt51.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt61.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt725.00
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd0X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd1X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd2X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd3X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd4X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd5X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd6X
IRS990/Form990PartVIISectionAGrp/OfficerInd0X
IRS990/Form990PartVIISectionAGrp/OfficerInd1X
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt00
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt10
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt20
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt30
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt40
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt50
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt60
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt70
IRS990/Form990PartVIISectionAGrp/PersonNm0ELEANOR LEDERER MD
IRS990/Form990PartVIISectionAGrp/PersonNm1MARTIN TRAXLER
IRS990/Form990PartVIISectionAGrp/PersonNm2MARY LEE ROTHSCHILD MD
IRS990/Form990PartVIISectionAGrp/PersonNm3LORA JOHNSON PHD
IRS990/Form990PartVIISectionAGrp/PersonNm4SATHYA KRISHNASAMY MD
IRS990/Form990PartVIISectionAGrp/PersonNm5MARTHA SPURLOCK
IRS990/Form990PartVIISectionAGrp/PersonNm6BILL SEILLER ATTORNEY
IRS990/Form990PartVIISectionAGrp/PersonNm7KIMBERLY KELLEY
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt00
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt10
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt20
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt30
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt40
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt50
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt60
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt746169
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt00
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt10
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt20
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt30
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt40
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt50
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt60
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt70
IRS990/Form990PartVIISectionAGrp/TitleTxt0CHAIR
IRS990/Form990PartVIISectionAGrp/TitleTxt1DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt2DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt3DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt4DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt5DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt6DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt7EXECUTIVE DI
IRS990/Form990ProvidedToGvrnBodyInd0true
IRS990/FormationYr01988
IRS990/FormerOfcrEmployeesListedInd0false
IRS990/FSAuditedBasisGrp/SeparateBasisFinclStmtInd0X
IRS990/FSAuditedInd0true
IRS990/FundraisingActivitiesInd0false
IRS990/GamingActivitiesInd0false
IRS990/GoverningBodyVotingMembersCnt07
IRS990/GrantsToIndividualsInd0false
IRS990/GrantsToOrganizationsInd0false
IRS990/GrantToRelatedPersonInd0false
IRS990/GrossReceiptsAmt0537657
IRS990/GroupReturnForAffiliatesInd0false
IRS990/IncludeFIN48FootnoteInd0true
IRS990/IndependentAuditFinclStmtInd0true
IRS990/IndependentVotingMemberCnt07
IRS990/IndoorTanningServicesInd0false
IRS990/InfoInScheduleOPartIIIInd0X
IRS990/InfoInScheduleOPartVIInd0X
IRS990/InformationTechnologyGrp/ManagementAndGeneralAmt0239
IRS990/InformationTechnologyGrp/ProgramServicesAmt0995
IRS990/InformationTechnologyGrp/TotalAmt01234
IRS990/InsuranceGrp/ManagementAndGeneralAmt02109
IRS990/InsuranceGrp/TotalAmt02109
IRS990/InvestmentIncomeGrp/ExclusionAmt02370
IRS990/InvestmentIncomeGrp/TotalRevenueColumnAmt02370
IRS990/InvestmentInJointVentureInd0false
IRS990/IRPDocumentCnt05
IRS990/IRPDocumentW2GCnt00
IRS990/LegalDomicileStateCd0KY
IRS990/LoanOutstandingInd0false
IRS990/LobbyingActivitiesInd0false
IRS990/LocalChaptersInd0false
IRS990/MaterialDiversionOrMisuseInd0false
IRS990/MembersOrStockholdersInd0false
IRS990/MethodOfAccountingAccrualInd0X
IRS990/MinutesOfCommitteesInd0true
IRS990/MinutesOfGoverningBodyInd0true
IRS990/MissionDesc0CLINICAL RESEARCH FOUNDATION, INC. FACILITATES RESEARCH AT THE ROBLEY REX VA MEDICAL CENTER (RRVAMC) IN LOUISVILLE, KY BY PROVIDING A MECHANISM FOR RRVAMC RESEARCHERS TO PARTICIPATE IN RESEARCH PROGRAMS INCLUDING CLINICAL TRIALS THAT ARE FUNDED BY PRIVATE OR NON-VA PUBLIC SOURCES.
IRS990/MoreThan5000KToIndividualsInd0false
IRS990/MoreThan5000KToOrgInd0false
IRS990/NetAssetsOrFundBalancesBOYAmt0711439
IRS990/NetAssetsOrFundBalancesEOYAmt0838275
IRS990/NondeductibleContributionsInd0false
IRS990/OfficeExpensesGrp/ManagementAndGeneralAmt0700
IRS990/OfficeExpensesGrp/ProgramServicesAmt042
IRS990/OfficeExpensesGrp/TotalAmt0742
IRS990/OfficerMailingAddressInd0false
IRS990/OperateHospitalInd0false
IRS990/Organization501c3Ind0X
IRS990/OrganizationFollowsSFAS117Ind0X
IRS990/OtherExpensesGrp/Desc0PROJECT COSTS
IRS990/OtherExpensesGrp/Desc1MEMBERSHIP DUES
IRS990/OtherExpensesGrp/Desc2PAYROLL SERVICES
IRS990/OtherExpensesGrp/Desc3ANIMAL COSTS
IRS990/OtherExpensesGrp/ManagementAndGeneralAmt03750
IRS990/OtherExpensesGrp/ManagementAndGeneralAmt12520
IRS990/OtherExpensesGrp/ProgramServicesAmt0122678
IRS990/OtherExpensesGrp/ProgramServicesAmt1319
IRS990/OtherExpensesGrp/ProgramServicesAmt21419
IRS990/OtherExpensesGrp/TotalAmt0122678
IRS990/OtherExpensesGrp/TotalAmt14069
IRS990/OtherExpensesGrp/TotalAmt22520
IRS990/OtherExpensesGrp/TotalAmt31419
IRS990/OtherSalariesAndWagesGrp/ManagementAndGeneralAmt09670
IRS990/OtherSalariesAndWagesGrp/ProgramServicesAmt0161518
IRS990/OtherSalariesAndWagesGrp/TotalAmt0171188
IRS990/OtherWebsiteInd0X
IRS990/PartialLiquidationInd0false
IRS990/PayPremiumsPrsnlBnftCntrctInd0false
IRS990/PayrollTaxesGrp/ManagementAndGeneralAmt04506
IRS990/PayrollTaxesGrp/ProgramServicesAmt013548
IRS990/PayrollTaxesGrp/TotalAmt018054
IRS990/PledgesAndGrantsReceivableGrp/BOYAmt053137
IRS990/PoliticalCampaignActyInd0false
IRS990/PrepaidExpensesDefrdChargesGrp/BOYAmt02078
IRS990/PrepaidExpensesDefrdChargesGrp/EOYAmt03196
IRS990/PrincipalOfficerNm0KIMBERLY KELLEY
IRS990/ProfessionalFundraisingInd0false
IRS990/ProgramServiceRevenueGrp/BusinessCd0621500
IRS990/ProgramServiceRevenueGrp/Desc0PROGRAM INCOME
IRS990/ProgramServiceRevenueGrp/RelatedOrExemptFuncIncomeAmt0535287
IRS990/ProgramServiceRevenueGrp/TotalRevenueColumnAmt0535287
IRS990/ProgSrvcAccomActy2Grp/Desc0PI-NAKAMATSU, RAUL, M.D. (NAKPFI) -- TO PROVIDE THE LOUISVILLE VA MEDICAL CENTER A BETTER UNDERSTANDING OF THE SIGNIFICANCE OF PNEUMOCOCCAL PNEUMONIA IN THEIR PATIENT POPULATION. SPECIFICALLY THE STUDY WILL DETERMINE EARLY AND LATE IMPROVEMENTS OR POSSIBLE COMPLICATIONS AND THEIR FREQUENCY IN HOSPITALIZED ADULT PATIENTS WITH PNEUMONIA TO ADDRESS SOME OF THE GAPS IN CURRENT KNOWLEDGE. PNEUMOCOCCAL COMMUNITY-ACQUIRED PNEUMONIA REPRESENTS A SIGNIFICANT CAUSE OF ILLNESS IN OLDER ADULTS, BOTH ACTIVE AND INACTIVE DUE TO NATURALLY WEAKENING OF THE IMMUNE SYSTEM THAT OCCURS WITH AGING.
IRS990/ProgSrvcAccomActy2Grp/ExpenseAmt0127303
IRS990/ProgSrvcAccomActy2Grp/RevenueAmt0293271
IRS990/ProgSrvcAccomActy3Grp/Desc0PI - GARRISON, M.D. (GARMCC, GARDONDO, GARDONSM) - TRAUMA WITH HEMORRHAGIC SHOCK IS A MAJOR PROBLEM FOR SOLDIERS. THERE ARE CRITICAL GUT-LIVER INTERACTION FOLLOWING HEMORRHAGIC SHOCK THAT CAN LEAD TO ALTERATIONS IN GUT: LIVER: BRAIN AXIS LEADING THE PATIENT TO A POOR OUTCOME. WE HYPOTHESIZED THAT GUT HYPOPERFUSION ALTERS INTESTINAL PERMEABILILTY AND LEADS TO TRANSLOCATION OF GUT-DERIVED TOXINS AND INCREASES HEPATIC INFLAMMATION/LIVER DYSFUNCTION. RESEARCH SO FAR INDICATES THAT DIRECT PERITONEAL RESUSCITATION (DPR) IMPROVED LIVER FUNCTION AND DIMINISHED LIVER INJURY (SERUM LIVER EMZYMES) IN RESUSCITATION HEMORRHAGIC SHOCK PATIENTS. IN ADDITION, LIVER HISTOPATHOLOGY WAS IMPROVED WHEN DPR WAS ADMINISTEREED AT THE TIME OF BLOOD AND SALINE RESUSCITATION, OR WHEN DELAYED UP TO 2 HOURS AFTER THE COMPLETION OF BLOOD AND FLUID.
IRS990/ProgSrvcAccomActy3Grp/ExpenseAmt052947
IRS990/ProgSrvcAccomActyOtherGrp/Desc0MARSANO, M.D. (GALECTIN) - TREATMENT OF LIVER FIBROSIS AND PORTAL HYPERTENTION IN PATIENTS WITH CIRRHOSIS. EXPENSE - 1,715. REVENUE - 8,125 MOKSHAGUNDAM, M.D. (BOEHRINGER INGELHEIM)(NOVO NORDISK) - DIABETIC CLINICAL TRIALS. EXPENSE - 3,515. REVENUE - 11,153. MATHESON, PHD (KENTUCKY ORGAN DONOR AFFILIATES) - INDUCED CELL DYSFUCTION IN BRAIN DEATH. EXPENSE - 5,298 REVENUE - 0 NAKAMATSU, M.D. (CEMPRA) - COMMUNITY-AQUIRED BACTERIAL PNEUMONIA DRUG THERAPY EXPENSE - 1,215 REVENUE - 0 PEYRANI, M.D. (PFIZER) - HOSPITALIZED ADULTS WITH PNEUMOCOCCAL INFECTION STUDY. EXPENSE - 0 REVENUE - 4,500 RESEARCH INITIATIVE - HIRED RESEARCH COORDINATOR AND MENTAL HEALTH FACILITATOR TO DEVELOP NEW RESEARCH PROJECTS. EXPENSE - 30,069 REVENUE - 0 STODDARD, M.D. (BRIGHAM WOMAN'S HOSPITAL)(PFIZER)(BOEHRINGER INGELHEIM) (NOVARTIS) - CARDIOVASCULAR STUDIES EXPENSE - 32,090 REVENUE - 83,114 OTHER PROJECT SUPPORT - VMU, HENDLER, M.D. PHARM, PROJECTS WITH REV/EXP< 2,000. EXPENSE - 10,355 REVENUE - 0
IRS990/ProgSrvcAccomActyOtherGrp/ExpenseAmt084257
IRS990/ProgSrvcAccomActyOtherGrp/RevenueAmt0106892
IRS990/ProhibitedTaxShelterTransInd0false
IRS990/PYContributionsGrantsAmt0806
IRS990/PYExcessBenefitTransInd0false
IRS990/PYInvestmentIncomeAmt01904
IRS990/PYOtherExpensesAmt0300286
IRS990/PYProgramServiceRevenueAmt0703269
IRS990/PYRevenuesLessExpensesAmt0134681
IRS990/PYSalariesCompEmpBnftPaidAmt0271012
IRS990/PYTotalExpensesAmt0571298
IRS990/PYTotalRevenueAmt0705979
IRS990/QuidProQuoContributionsInd0false
IRS990/RcvFndsToPayPrsnlBnftCntrctInd0false
IRS990/ReconcilationRevenueExpnssAmt0126836
IRS990/RegularMonitoringEnfrcInd0true
IRS990/RelatedEntityInd0false
IRS990/RelatedOrganizationCtrlEntInd0false
IRS990/ReportInvestmentsOtherSecInd0false
IRS990/ReportLandBuildingEquipmentInd0false
IRS990/ReportOtherAssetsInd0false
IRS990/ReportOtherLiabilitiesInd0false
IRS990/ReportProgramRelatedInvstInd0false
IRS990/RevenueAmt0135124
IRS990/SavingsAndTempCashInvstGrp/BOYAmt0152000
IRS990/SavingsAndTempCashInvstGrp/EOYAmt0449000
IRS990ScheduleA/HospitalNameAndAddressGrp/CityNm0LOUISVILLE
IRS990ScheduleA/HospitalNameAndAddressGrp/StateAbbreviationCd0KY
IRS990ScheduleA/HospitalNameAndAddressGrp/SupportedOrganizationName/BusinessNameLine1Txt0ROBLEY REX VA MEDICAL CENTER
IRS990ScheduleA/MedicalResearchOrganizationInd0X
IRS990/ScheduleBRequiredInd0false
IRS990ScheduleD/ExpensesSubtotalAmt0410821
IRS990ScheduleD/FootnoteTextInd0X
IRS990ScheduleD/RevenueSubtotalAmt0537657
IRS990ScheduleD/SupplementalInformationDetail/ExplanationTxt0MANAGEMENT HAS CONCLUDED THAT ANY TAX POSITIONS THAT WOULD NOT MEET THE MORE LIKELY-THAN-NOT CRITERION OF FASB ASC 740-10 WOULD BE IMMATERIAL TO THE FINANCIAL STATEMENTS TAKEN AS A WHOLE. ACCORDINGLY, THE ACCOMPANYING FINANCIAL STATEMENTS DO NOT INCLUDE ANY PROVISION FOR UNCERTAIN TAX POSITIONS, AND NO RELATED INTEREST OR PENALTIES HAVE BEEN RECORDED IN THE STATEMENT OF REVENUE, EXPENSES AND OTHER CHANGES IN NET ASSETS OR ACCRUED IN THE STATEMENT OF ASSETS AND NET ASSETS.
IRS990ScheduleD/SupplementalInformationDetail/FormAndLineReferenceDesc0SCHEDULE D, PAGE 3, PART X
IRS990ScheduleD/TotalExpensesPerForm990Amt0410821
IRS990ScheduleD/TotalRevenuePerForm990Amt0537657
IRS990ScheduleD/TotalRevEtcAuditedFinclStmtAmt0537657
IRS990ScheduleD/TotExpnsEtcAuditedFinclStmtAmt0410821
IRS990/ScheduleJRequiredInd0false
IRS990/ScheduleORequiredInd0true
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt0CLINICAL RESEARCH FOUNDATION, INC. FACILITATES RESEARCH AT THE ROBLEY REX VA MEDICAL CENTER (RRVAMC) IN LOUISVILLE, KY BY PROVIDING A MECHANISM FOR RRVAMC RESEARCHERS TO PARTICIPATE IN RESEARCH PROGRAMS INCLUDING CLINICAL TRIALS THAT ARE FUNDED BY PRIVATE OR NON-VA PUBLIC SOURCES.
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt1HOURS AFTER THE COMPLETION OF BLOOD AND FLUID.
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt2MARSANO, M.D. (GALECTIN) - TREATMENT OF LIVER FIBROSIS AND PORTAL HYPERTENTION IN PATIENTS WITH CIRRHOSIS. EXPENSE - 1,715. REVENUE - 8,125 MOKSHAGUNDAM, M.D. (BOEHRINGER INGELHEIM)(NOVO NORDISK) - DIABETIC CLINICAL TRIALS. EXPENSE - 3,515. REVENUE - 11,153. MATHESON, PHD (KENTUCKY ORGAN DONOR AFFILIATES) - INDUCED CELL DYSFUCTION IN BRAIN DEATH. EXPENSE - 5,298 REVENUE - 0 NAKAMATSU, M.D. (CEMPRA) - COMMUNITY-AQUIRED BACTERIAL PNEUMONIA DRUG THERAPY EXPENSE - 1,215 REVENUE - 0 PEYRANI, M.D. (PFIZER) - HOSPITALIZED ADULTS WITH PNEUMOCOCCAL INFECTION STUDY. EXPENSE - 0 REVENUE - 4,500 RESEARCH INITIATIVE - HIRED RESEARCH COORDINATOR AND MENTAL HEALTH FACILITATOR TO DEVELOP NEW RESEARCH PROJECTS. EXPENSE - 30,069 REVENUE - 0 STODDARD, M.D. (BRIGHAM WOMAN'S HOSPITAL)(PFIZER)(BOEHRINGER INGELHEIM) (NOVARTIS) - CARDIOVASCULAR STUDIES EXPENSE - 32,090 REVENUE - 83,114 OTHER PROJECT SUPPORT - VMU, HENDLER, M.D. PHARM, PROJECTS WITH REV/EXP< 2,000. EXPENSE - 10,355 REVENUE - 0
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt3THE FORM 990 IS REVIEWED AND APPROVED BY THE ENTIRE BOARD AT A SCHEDULED MEETING.
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt4ON AN ANNUAL BASIS THE BOARD OF DIRECTORS/OFFICERS/EMPLOYEES MUST ANSWER AND SIGN A SPECIFIC QUESTIONNAIRE DESIGNED TO HIGHLIGHT ANY POTENTIAL CONFILICT OF INTEREST. THE QUESTIONNAIRE IS REVIEWED AND HOUSED BY CRF ADMINISTRATION.
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt5COMPENSATION DETERMINATION FOR THE EXECUTIVE DIRECTOR MUST BE REVIEWED AND APPROVED BY THE BOARD OF DIRECTORS.
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt6UPON REQUEST.
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc0FORM 990 - ORGANIZATION'S MISSION
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc1FORM 990, PAGE 2, PART III, LINE 4C
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc2FORM 990, PAGE 2, PART III, LINE 4D
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc3FORM 990, PAGE 6, PART VI, LINE 11B
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc4FORM 990, PAGE 6, PART VI, LINE 12C
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc5FORM 990, PAGE 6, PART VI, LINE 15A
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc6FORM 990, PAGE 6, PART VI, LINE 19
IRS990/SchoolOperatingInd0false
IRS990/SignificantChangeInd0false
IRS990/SignificantNewProgramSrvcInd0false
IRS990/StatesWhereCopyOfReturnIsFldCd0KY
IRS990/SubjectToProxyTaxInd0false
IRS990/TaxablePartyNotificationInd0false
IRS990/TaxExemptBondsInd0false
IRS990/TempOrPermanentEndowmentsInd0false
IRS990/TerminateOperationsInd0false
IRS990/TotalAssetsBOYAmt0733292
IRS990/TotalAssetsEOYAmt0863667
IRS990/TotalAssetsGrp/BOYAmt0733292
IRS990/TotalAssetsGrp/EOYAmt0863667
IRS990/TotalCompGreaterThan150KInd0false
IRS990/TotalEmployeeCnt014
IRS990/TotalFunctionalExpensesGrp/FundraisingAmt00
IRS990/TotalFunctionalExpensesGrp/ManagementAndGeneralAmt079105
IRS990/TotalFunctionalExpensesGrp/ProgramServicesAmt0331716
IRS990/TotalFunctionalExpensesGrp/TotalAmt0410821
IRS990/TotalGrossUBIAmt00
IRS990/TotalLiabilitiesBOYAmt021853
IRS990/TotalLiabilitiesEOYAmt025392
IRS990/TotalLiabilitiesGrp/BOYAmt021853
IRS990/TotalLiabilitiesGrp/EOYAmt025392
IRS990/TotalNetAssetsFundBalanceGrp/BOYAmt0711439
IRS990/TotalNetAssetsFundBalanceGrp/EOYAmt0838275
IRS990/TotalOtherProgSrvcExpenseAmt084257
IRS990/TotalOtherProgSrvcRevenueAmt0106892
IRS990/TotalProgramServiceExpensesAmt0331716
IRS990/TotalProgramServiceRevenueAmt0535287
IRS990/TotalReportableCompFromOrgAmt046169
IRS990/TotalRevenueGrp/ExclusionAmt02370
IRS990/TotalRevenueGrp/RelatedOrExemptFuncIncomeAmt0535287
IRS990/TotalRevenueGrp/TotalRevenueColumnAmt0537657
IRS990/TotalVolunteersCnt07
IRS990/TotLiabNetAssetsFundBalanceGrp/BOYAmt0733292
IRS990/TotLiabNetAssetsFundBalanceGrp/EOYAmt0863667
IRS990/TravelGrp/ManagementAndGeneralAmt01050
IRS990/TravelGrp/ProgramServicesAmt0635
IRS990/TravelGrp/TotalAmt01685
IRS990/TrnsfrExmptNonChrtblRltdOrgInd0false
IRS990/TypeOfOrganizationCorpInd0X
IRS990/UnrelatedBusIncmOverLimitInd0false
IRS990/UnrestrictedNetAssetsGrp/BOYAmt0711439
IRS990/UnrestrictedNetAssetsGrp/EOYAmt0838275
IRS990/UponRequestInd0X
IRS990/VotingMembersGoverningBodyCnt07
IRS990/VotingMembersIndependentCnt07
IRS990/WebsiteAddressTxt0N/A
IRS990/WhistleblowerPolicyInd0true
ReturnHeader/BuildTS02017-02-10 21:41:12Z
ReturnHeader/BusinessOfficerGrp/PersonNm0KIMBERLY KELLEY
ReturnHeader/BusinessOfficerGrp/PersonTitleTxt0EXECUTIVE DIRECTOR
ReturnHeader/BusinessOfficerGrp/PhoneNum05022876260
ReturnHeader/BusinessOfficerGrp/SignatureDt02017-04-25
ReturnHeader/Filer/BusinessName/BusinessNameLine1Txt0CLINICAL RESEARCH FOUNDATION INC
ReturnHeader/Filer/BusinessNameControlTxt0CLIN
ReturnHeader/Filer/EIN0611144514
ReturnHeader/Filer/PhoneNum05022876260
ReturnHeader/Filer/USAddress/AddressLine1Txt0800 ZORN AVENUE SUITE 151
ReturnHeader/Filer/USAddress/CityNm0LOUISVILLE
ReturnHeader/Filer/USAddress/StateAbbreviationCd0KY
ReturnHeader/Filer/USAddress/ZIPCd040206
ReturnHeader/FilingSecurityInformation/AtSubmissionCreationDeviceId072A9AB7397B853419F7BC1FB2C0C199BD4BCD0FA
ReturnHeader/FilingSecurityInformation/AtSubmissionFilingDeviceId0E8853820BC97883E6A715588E1E70A1C8EBEA6EE
ReturnHeader/PreparerFirmGrp/PreparerFirmEIN0201416603
ReturnHeader/PreparerFirmGrp/PreparerFirmName/BusinessNameLine1Txt0BALDWIN CPAS PLLC
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/AddressLine1Txt0943 S 1ST STREET
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/CityNm0LOUISVILLE
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/StateAbbreviationCd0KY
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/ZIPCd040203
ReturnHeader/PreparerPersonGrp/PhoneNum05025849793
ReturnHeader/PreparerPersonGrp/PreparationDt02017-05-02
ReturnHeader/PreparerPersonGrp/PreparerPersonNm0BARBARA LASKY
ReturnHeader/ReturnTs02017-05-02T13:44:32-04:00
ReturnHeader/ReturnTypeCd0990
ReturnHeader/TaxPeriodBeginDt02016-01-01
ReturnHeader/TaxPeriodEndDt02016-12-31
ReturnHeader/TaxYr02016

Document Assets

No mirrored PDF or thumbnail assets are attached yet.

Filings

Balance SheetOperations
YearAssetsLiabilitiesNet AssetsRevenueExpensesNet Income
2024Detailed filing. Detailed filing data is available for this year.$3.95$0.65$3.30$3.75$2.88$0.87
2023Detailed filing. Detailed filing data is available for this year.$2.56$0.03$2.54$3.31$3.09$0.21
2022Detailed filing. Detailed filing data is available for this year.$2.32$0.00$2.32$3.88$3.95$0.07
2021Detailed filing. Detailed filing data is available for this year.$2.67$0.00$2.67$6.28$6.00$0.28
2020Detailed filing. Detailed filing data is available for this year.$2.45$0.06$2.39$4.49$5.23$0.74
2019Summary only. Only limited summary data is available for this year.$3.27$0.12$3.15$2.60$3.88$1.29
2018Detailed filing. Detailed filing data is available for this year.$4.82$0.39$4.43$2.64$4.45$1.81
2017Summary only. Only limited summary data is available for this year.$6.73$0.48$6.24$1.95$4.09$2.14
2016Detailed filing. Detailed filing data is available for this year.$8.64$0.25$8.38$5.38$4.11$1.27
2015Detailed filing. Detailed filing data is available for this year.$7.33$0.22$7.11$7.06$5.71$1.35
2014Detailed filing. Detailed filing data is available for this year.$5.79$0.02$5.77$4.85$5.84$0.99
2013Detailed filing. Detailed filing data is available for this year.$6.74$0.00$6.74$6.41$6.70$0.28
2012Facts available. Structured filing facts are available, but richer extracted sections are limited.$7.03$0.00$7.03$3.89
2011Facts available. Structured filing facts are available, but richer extracted sections are limited.$4.95$0.00$4.95$3.66
2010Facts available. Structured filing facts are available, but richer extracted sections are limited.$3.82$0.00$3.82$3.43